Otto-Wilhelm Merten

1.6k total citations
27 papers, 1.2k citations indexed

About

Otto-Wilhelm Merten is a scholar working on Molecular Biology, Genetics and Infectious Diseases. According to data from OpenAlex, Otto-Wilhelm Merten has authored 27 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 19 papers in Genetics and 6 papers in Infectious Diseases. Recurrent topics in Otto-Wilhelm Merten's work include Viral Infectious Diseases and Gene Expression in Insects (21 papers), Virus-based gene therapy research (16 papers) and RNA Interference and Gene Delivery (6 papers). Otto-Wilhelm Merten is often cited by papers focused on Viral Infectious Diseases and Gene Expression in Insects (21 papers), Virus-based gene therapy research (16 papers) and RNA Interference and Gene Delivery (6 papers). Otto-Wilhelm Merten collaborates with scholars based in France, Austria and Portugal. Otto-Wilhelm Merten's co-authors include Matthias Hebben, Chiara Bovolenta, Matthias Schweizer, Glyn Stacey, William S. Stokes, John M. Davis, Robert J. Hay, Sandra Coecke, Gerhard Gstraunthaler and Anna Price and has published in prestigious journals such as Journal of Virology, Biotechnology and Bioengineering and Vaccine.

In The Last Decade

Otto-Wilhelm Merten

27 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Otto-Wilhelm Merten France 17 864 596 202 166 137 27 1.2k
Michael McCaman United States 16 526 0.6× 267 0.4× 171 0.8× 85 0.5× 128 0.9× 28 953
Jarmo Wahlfors Finland 28 1.1k 1.2× 555 0.9× 211 1.0× 126 0.8× 47 0.3× 71 1.7k
Christoph Weigel Germany 23 1.1k 1.3× 823 1.4× 120 0.6× 50 0.3× 52 0.4× 51 1.5k
Kathleen Hehir United States 15 973 1.1× 791 1.3× 212 1.0× 182 1.1× 22 0.2× 18 1.5k
Joe Hedgpeth United States 19 1.1k 1.3× 589 1.0× 112 0.6× 54 0.3× 56 0.4× 26 1.6k
Steven R. Williams United States 18 597 0.7× 252 0.4× 168 0.8× 108 0.7× 56 0.4× 25 1.0k
David Ruano‐Gallego Spain 17 487 0.6× 240 0.4× 140 0.7× 138 0.8× 74 0.5× 30 946
Markus Wolschek Austria 19 947 1.1× 230 0.4× 219 1.1× 96 0.6× 247 1.8× 34 1.4k
Laurie S. Moran United States 15 1.1k 1.3× 505 0.8× 50 0.2× 77 0.5× 80 0.6× 23 1.4k
Diane Sutter Germany 12 610 0.7× 381 0.6× 92 0.5× 70 0.4× 51 0.4× 14 1.2k

Countries citing papers authored by Otto-Wilhelm Merten

Since Specialization
Citations

This map shows the geographic impact of Otto-Wilhelm Merten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Otto-Wilhelm Merten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Otto-Wilhelm Merten more than expected).

Fields of papers citing papers by Otto-Wilhelm Merten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Otto-Wilhelm Merten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Otto-Wilhelm Merten. The network helps show where Otto-Wilhelm Merten may publish in the future.

Co-authorship network of co-authors of Otto-Wilhelm Merten

This figure shows the co-authorship network connecting the top 25 collaborators of Otto-Wilhelm Merten. A scholar is included among the top collaborators of Otto-Wilhelm Merten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Otto-Wilhelm Merten. Otto-Wilhelm Merten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Merten, Otto-Wilhelm, Matthias Hebben, & Chiara Bovolenta. (2016). Production of lentiviral vectors. Molecular Therapy — Methods & Clinical Development. 3. 16017–16017. 207 indexed citations
2.
Merten, Otto-Wilhelm, Matthias Schweizer, Parminder S. Chahal, & Amine Kamen. (2014). Manufacturing of viral vectors: part II. Downstream processing and safety aspects. HAL (Le Centre pour la Communication Scientifique Directe). 2(3). 237–251. 23 indexed citations
3.
Marek, Martin, Christophe Romier, Lionel Galibert, Otto-Wilhelm Merten, & Monique M. van Oers. (2013). Baculovirus VP1054 Is an Acquired Cellular PURα, a Nucleic Acid-Binding Protein Specific for GGN Repeats. Journal of Virology. 87(15). 8465–8480. 16 indexed citations
4.
Marek, Martin, Otto-Wilhelm Merten, Lionel Galibert, Just M. Vlak, & Monique M. van Oers. (2011). Baculovirus VP80 Protein and the F-Actin Cytoskeleton Interact and Connect the Viral Replication Factory with the Nuclear Periphery. Journal of Virology. 85(11). 5350–5362. 53 indexed citations
5.
Stacey, Glyn & Otto-Wilhelm Merten. (2011). Host Cells and Cell Banking. Methods in molecular biology. 737. 45–88. 13 indexed citations
6.
Rivière, C., et al.. (2010). Baculovirus deleted for chitinase, cathepsin and p10 genes improves purified rAAV8 quality. Socio-Environmental Systems Modeling. 42–42. 1 indexed citations
7.
Schweizer, Matthias & Otto-Wilhelm Merten. (2010). Large-Scale Production Means for the Manufacturing of Lentiviral Vectors. Current Gene Therapy. 10(6). 474–486. 55 indexed citations
8.
Carrondo, Manuel J.T., Amos Panet, Dagmar Wirth, et al.. (2010). Integrated Strategy for the Production of Therapeutic Retroviral Vectors. Human Gene Therapy. 22(3). 370–379. 5 indexed citations
9.
Merten, Otto-Wilhelm. (2007). Attention with virus contaminated cell lines. Cytotechnology. 55(1). 1–2. 5 indexed citations
10.
Coroadinha, Ana S., António Roldão, Pedro E. Cruz, et al.. (2006). Effect of medium sugar source on the production of retroviral vectors for gene therapy. Biotechnology and Bioengineering. 94(1). 24–36. 24 indexed citations
11.
Merten, Otto-Wilhelm, et al.. (2001). Comparison of Different Bioreactor Systems for the Production of High Titer Retroviral Vectors. Biotechnology Progress. 17(2). 326–335. 55 indexed citations
12.
Merten, Otto-Wilhelm. (2000). Safety for vaccine(e)s. Cytotechnology. 34(3). 181–183. 5 indexed citations
13.
Merten, Otto-Wilhelm, et al.. (1996). Production of Influenza Virus in Cell Cultures for Vaccine Preparation. Advances in experimental medicine and biology. 397. 141–151. 48 indexed citations
14.
15.
Merten, Otto-Wilhelm, et al.. (1994). Modified monoclonal antibody production kinetics kappa/gamma mRNA levels, and metabolic activities in a murine hybridoma selected by continuous Culture. Biotechnology and Bioengineering. 44(6). 753–764. 10 indexed citations
16.
Merten, Otto-Wilhelm, et al.. (1994). Evaluation of the new serum-free medium (MDSS2) for the production of different biologicals: Use of various cell lines. Cytotechnology. 14(1). 47–59. 36 indexed citations
17.
Merten, Otto-Wilhelm, et al.. (1991). A new method for the encapsulation of mammalian cells. Cytotechnology. 7(2). 121–130. 15 indexed citations
18.
Merten, Otto-Wilhelm, et al.. (1990). Batch production and secretion kinetics of hybridomas: Pulse-chase experiments. Cytotechnology. 4(1). 77–89. 7 indexed citations
19.
Merten, Otto-Wilhelm. (1988). Batch production and growth kinetics of hybridomas. Cytotechnology. 1(2). 113–121. 36 indexed citations
20.
Merten, Otto-Wilhelm, et al.. (1983). Purification of HBsAg produced by the human hepatoma cell line PLC/PRE/5 by affinity chromatography using monoclonal antibodies and application for ELISA diagnostic.. PubMed. 55. 121–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael McCaman Breakdown of academic impact, for papers by Jarmo Wahlfors Breakdown of academic impact, for papers by Christoph Weigel Breakdown of academic impact, for papers by Kathleen Hehir Breakdown of academic impact, for papers by Joe Hedgpeth Breakdown of academic impact, for papers by Steven R. Williams Breakdown of academic impact, for papers by David Ruano‐Gallego Breakdown of academic impact, for papers by Markus Wolschek Breakdown of academic impact, for papers by Laurie S. Moran Breakdown of academic impact, for papers by Diane Sutter
Rankless by CCL
2026